Novel Subtypes of Polycystic Ovary Syndrome - Trial NCT06124391
Access comprehensive clinical trial information for NCT06124391 through Pure Global AI's free database. This phase not specified trial is sponsored by Shandong University and is currently Recruiting. The study focuses on Polycystic Ovary Syndrome. Target enrollment is 50000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Shandong University
Timeline & Enrollment
N/A
Jan 01, 2021
Dec 30, 2025
Primary Outcome
Persistence of PCOS Diagnosis,Changes in PCOS Subtype,Body Mass Index,Non-Alcoholic Fatty Liver Disease (NAFLD),Hypertension,Type 2 Diabetes Mellitus (T2DM),Dyslipidemia,Total live birth rate,Clinical pregnancy rate,Pregnancy loss rate,Maternal and neonatal complications
Summary
To classify subtypes of Polycystic Ovary Syndrome (PCOS) using machine-learning algorithms,
 and compare the reproductive and metabolic characteristics and IVF outcomes across these
 identified subtypes.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06124391
Non-Device Trial